The Application of Molecular Techniques for Assessment of SOX2 and miR126 Expression as Prognostic Markers in Esophageal Carcinoma.
Amal F GharibWael H ElsawyAmani A AlrehailiHanan S AminHayaa M AlhuthaliMaha M BakhuraysahAhmad A El AskaryPublished in: Computational and mathematical methods in medicine (2022)
In esophageal cancer, SOX2 works as an oncogene, whereas miR-126 acts as a tumor suppressor gene. SOX2 overexpression and miR-126 downregulation were shown to be linked to a poor prognosis.